Psychedelics COMPASS Pathways reports 52% YoY cash loss The company had $126.6M less last quarter than it did in Q1 last year Rowan DunneMay 12, 2023
Psychedelics Optimi Health enters $1.2M psilocybin distribution agreement The mushroom cultivator will be supplying a private client for clinical research purposes Rowan DunneMay 4, 2023
Psychedelics Psyched Wellness Amanita muscaria extract shows potential for brain health improvement The study found that the extract activates specialized cells within the brain Rowan DunneMay 3, 2023
Psychedelics University of Exeter launches postgrad psychedelics certificate program The online program 'Psychedelics: Mind, Medicine, and Culture' was announced at the Breaking Convention conference last week Rowan DunneApril 28, 2023
Stock News Reunion Neuroscience struggles to maintain Nasdaq listing requirements The company has until mid-October to fulfill the requirements before the exchange takes further action Rowan DunneApril 26, 2023
Psychedelics International psychedelics market to reach US$8.3B by 2027: ReportLinker The market was valued at US$4.83B this year and will rise with a CAGR of 14.5 per cent Rowan DunneApril 24, 2023
Psychedelics Mydecine’s MDMA with rapid onset and a short duration shows promising results The effects from the company's MYCO-006 compounds last for only two hours and set in four times as fast Rowan DunneApril 24, 2023
Psychedelics LSD helps alleviate anxiety and major depression symptoms: MindMed Participants in a recent study saw statistically significant improvements in their MDD symptoms Rowan DunneApril 14, 2023
Psychedelics MGC Pharma gets permission from Slovenian health authorities to research psilocybin MGC says it is the first company operating in Slovenia to obtain permission to engage in studies on the psychedelic compound Rowan DunneApril 5, 2023
Psychedelics Dutch government establishes MDMA research commission The commission will be investigating the risks and benefits associated with MDMA-assisted therapy Rowan DunneMarch 31, 2023